Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(3)
•••
antigua1987
X
Post by
antigua1987
on Mar 08, 2023 7:24am
Andy has left the building ...
By saying so little, he might actually have checked out. Or maybe this is the strong, silent type routine. Until the curtains pulled back. Cmon change the world guy, earn your pay. Speak
...more
(1)
•••
Jthom376
X
Comment by
Jthom376
on Feb 22, 2023 6:08pm
RE:Slow dive to oblivion
18 or so months back a question was asked on this current DLBCL flipping to registrational at a specific point. They stated such was on the table. I would assume it being designed with 100 plus
...more
(10)
•••
prosciutto
X
Post by
prosciutto
on Feb 22, 2023 12:27pm
Slow dive to oblivion
Im going to guess that longs are going to hold till the end. No point in selling when your down 98%. I've lost a s%^& load on this. I was just wondering if there are any scenarios where IMV
...more
(2)
•••
europe10
X
Comment by
europe10
on Feb 17, 2023 2:39pm
RE:Shareprice
I have learned through my years Management. It is all abut management IMV NEVER had In fact, it got worse through the years IMV is one of many companies in the space. Like many Canadian
...more
(11)
•••
DaveInvestor59
X
Comment by
DaveInvestor59
on Feb 17, 2023 11:33am
RE:RE:Shareprice
They are pretty pathetic managers of their own stock. My original investment is down 95% with no upside in sight for now. With that kind of a loss in share value IMV has no business even being listed.
(10)
•••
prosciutto
X
Post by
prosciutto
on Feb 15, 2023 1:00pm
No Reaction
Still waiting on some kind of reaction from IMV. No press release, no attempt at all to stop the bleed. Like nothing happened. Maybe a hostile takeover is what we need at this point. Unless of course
...more
(48)
•••
Hideaway
X
Post by
Hideaway
on Feb 14, 2023 5:37pm
IO 360 Agenda
Delivery Matters: Leveraging the DPX Cancer Vaccine Platform to Educate Sustained Anti-cancer Immunity and Durable Clinical Benefit This talk addresses: The unique capability of the DPX
...more
(10)
•••
prosciutto
X
Comment by
prosciutto
on Feb 14, 2023 5:30pm
RE:RE:RE:RE:Shareprice
wow, i have just 1 question, doesnt the market regulate this kind of thing and stop trading if it sees suspicious activity?
(1)
•••
TommyD
X
Comment by
TommyD
on Feb 14, 2023 3:50pm
RE:RE:RE:Shareprice
It technically is illegal, just as naked shorting is illegal. Unfortunately it happens every day. There are many ways around the legality of this and the regulators are not out to protect the average
...more
(10)
•••
prosciutto
X
Comment by
prosciutto
on Feb 14, 2023 3:26pm
RE:RE:Shareprice
This must be illegal? They cant drive the stock down using their own shares if they are shorting?
(1)
•••
TommyD
X
Comment by
TommyD
on Feb 14, 2023 12:38pm
RE:Shareprice
They got into bed with sharks on their last raise and are paying the price. Pretty standard story especially in biotech. The entity involved in the raise had no hold period and has an exemption to
...more
(2)
•••
europe10
X
Comment by
europe10
on Feb 14, 2023 11:26am
RE:Comments on Calandra's Take?
Calandra used to be very positive. Friend of Fred Ors? Since he is gone Calandra has been negative. Though he has some valid points Value of the company is now so small, that a financing is almost
...more
(10)
•••
prosciutto
X
Post by
prosciutto
on Feb 13, 2023 6:40pm
Comments on Calandra's Take?
I agree with most of this. By sub-par I assume he means the # of participants https://mailchi.mp/5d84acaf42fe/imv-relapses-thank-goodness-for-ivn-xtg-vgcx-agi-9301009?e=804db9ee01
(48)
•••
Hideaway
X
Post by
Hideaway
on Feb 13, 2023 12:54pm
Shareprice
Can anyone shed light on why we have lost about one third of our SP over the last three trading. The NR re the Vitalize study seems to have presitaped a lot of the loss,The results seemed very
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Feb 13, 2023 7:06am
New Press Release - IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial
Early analysis reveals clinically meaningful activity in refractory DLBCL patientsMultiple confirmed complete responses observed in heavily pre-treated patientsNo adverse safety and tolerability signal reported, consistent with previous clinical trials IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*